Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001930759 | SCV002193617 | uncertain significance | not provided | 2022-09-23 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on WFS1 protein function. ClinVar contains an entry for this variant (Variation ID: 1415009). This variant has not been reported in the literature in individuals affected with WFS1-related conditions. This variant is present in population databases (rs753237278, gnomAD 0.03%). This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 562 of the WFS1 protein (p.Gly562Ser). |
Fulgent Genetics, |
RCV002491877 | SCV002781848 | uncertain significance | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | 2022-01-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002556405 | SCV003643158 | uncertain significance | Inborn genetic diseases | 2022-10-21 | criteria provided, single submitter | clinical testing | Unlikely to be causative of autosomal dominant WFS1-related Wolfram syndrome Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |